Question 1

How will the ctDNA test be used in my treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Measuring Molecular Residual Disease in Colorectal Cancer After Primary Surgery and Resection of Metastases clinical trial (NCT03189576). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential benefits of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Measuring Molecular Residual Disease in Colorectal Cancer After Primary Surgery and Resection of Metastases clinical trial (NCT03189576). Contact the study team or your healthcare provider for specific answers.

Question 3

Are there any risks or side effects associated with the blood draw?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Measuring Molecular Residual Disease in Colorectal Cancer After Primary Surgery and Resection of Metastases clinical trial (NCT03189576). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for blood tests?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Measuring Molecular Residual Disease in Colorectal Cancer After Primary Surgery and Resection of Metastases clinical trial (NCT03189576). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if the ctDNA test shows residual disease?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Measuring Molecular Residual Disease in Colorectal Cancer After Primary Surgery and Resection of Metastases clinical trial (NCT03189576). Contact the study team or your healthcare provider for specific answers.

Question 6

Will my participation affect my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Measuring Molecular Residual Disease in Colorectal Cancer After Primary Surgery and Resection of Metastases clinical trial (NCT03189576). Contact the study team or your healthcare provider for specific answers.

What this study is about